Synthetic Peptide
TMEM106A Synthetic Peptide, PEP-1395, from Invitrogen.
Transmembrane protein 106A (TMEM106A) is a single-pass transmembrane protein that is closely related to TMEM106B, a protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual roles of TMEM106A and TMEM106B are still undetermined; however, as TMEM106B is involved in FTLD, it is possible that TMEM106A may also be a risk factor for FTLD.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-176225 |
| Réf. fabricant | 15205309 |
| Gene ID (Entrez) | 113277 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q96A25 |
| Nom usuel | Human TMEM106A |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | TMEM106A |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
